SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-019844
Filing Date
2022-05-12
Accepted
2022-05-12 16:06:35
Documents
82
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q1 2022 kdny-10q_20220331.htm   iXBRL 10-Q 2774887
2 EX-31.1 kdny-ex311_6.htm EX-31.1 21120
3 EX-31.2 kdny-ex312_8.htm EX-31.2 21413
4 EX-32.1 kdny-ex321_7.htm EX-32.1 8132
  Complete submission text file 0001564590-22-019844.txt   10581466

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA kdny-20220331.xsd EX-101.SCH 69661
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kdny-20220331_cal.xml EX-101.CAL 65445
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kdny-20220331_def.xml EX-101.DEF 192042
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE kdny-20220331_lab.xml EX-101.LAB 489245
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kdny-20220331_pre.xml EX-101.PRE 384740
76 EXTRACTED XBRL INSTANCE DOCUMENT kdny-10q_20220331_htm.xml XML 2258134
Mailing Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109
Business Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109 206-485-7051
CHINOOK THERAPEUTICS, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37345 | Film No.: 22917780
SIC: 2834 Pharmaceutical Preparations